Novartis as a focused innovative medicines company

Novartis is transforming into a ‘pure-play’ Innovative Medicines company.
Our focused strategy, core therapeutic areas, technology platforms, priority geographies and a deep, value-oriented pipeline are central to becoming the most valued and trusted medicines company in the world.
In a recent Meet Novartis Management Investor Relations session, Vas Narasimhan, Novartis Chief Executive Officer shared information on our refreshed strategy and approach to create value for our shareholders, patients, associates and society.
Meet Novartis Management
Event Date: September 22, 2022
Investors Page: bit.ly/3GR69sV
Link to Novartis Strategy: bit.ly/3D1U173
Disclaimer: Meet Novartis Management event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: bit.ly/3JaKJcK
Follow @Novartis on Twitter: / novartis
Follow Novartis on LinkedIn: / novartis